Wockhardt Shares
- All
- News
- Videos
-
Wockhardt Shares Hit Upper Limit For Second Straight Day On COVID-19 Vaccine Supply To UK
On Monday, Wockhardt entered into a fill-and-finish agreement with the UK government to supply COVID-19 vaccines
-
Wockhardt To Supply Coronavirus Vaccine To UK Government, Shares Soar 10%
Wockhardt said it will manufacture the product at its Wrexham, North Wales-based subsidiary, CP Pharmaceuticals.
-
Wockhardt To Supply COVID-19 Vaccines To UK
AstraZeneca has indicated it would need 30 million fill-and-finish doses of their vaccine candidate, which the company intends to supply in the next few months, Wockhardt's chairman said.
-
Wockhardt Rises On US FDA Nod For Cancer Drug Decitabine
Wockhardt's Decitabine Injection is a generic version of Dacogen, marketed in USA and other countries by Otsuka.
-
Wockhardt Shareholders Approve Raising Of Upto Rs 1,000 Crore
Wockhardt has three research centres and 12 manufacturing plants, with businesses ranging from the making and marketing of pharmaceuticals, active pharmaceutical ingredients (APIs) and vaccines.
-
Top 5 Pharma Companies Lose 19,000 Crore In Market Value. Here Is Why
Analysts say the fresh selloff in the pharmaceutical shares has been triggered after Sun Pharma's US-based subsidiary Taro Pharmaceuticals reported a weak set of earnings in the March quarter.
-
Wockhardt Plunges After US Drug Regulator Warns Subsidiary
After a weak opening, shares of the company further went down by 6.67 per cent to Rs 701 on BSE.
-
Wockhardt Surges 8% As German Regulator Clears Ankaleshwar Plant
Shares of pharmaceutical company Wockhardt surged as much as 8 per cent to hit intraday high of Rs 728.
-
Wockhardt Shares Jump 3% On UK Health Regulator Approval
On BSE, the scrip opened at Rs 699 and jumped 3.24 per cent to an early high of Rs 704. At 1147 hours, it was trading at Rs 689.50, up 1.11 per cent.
-
Wockhardt Tanks 5% On Weak Q2 Numbers
Shares of Drug firm Wockhardt on Friday tumbled over 5 per cent after the company reported 81.59 per cent dip in consolidated net profit to Rs 17 crore for the September quarter of the current fiscal.
-
Wockhardt Surges 5% As US Drug Regulator Excludes Drug From Import Alert
Shares of Wockhardt Ltd jumped as much as 4.75 per cent to hit intraday high of Rs 937 after the US drug regulator excluded one of its drugs from import alert it had issued to the company in August.
-
Wockhardt Rises As UK Regulator Completes Inspection Of Key Plant
Shares of drug manufacturer Wockhardt rose as much as 4.46 per cent to hit intraday high of Rs 945 after the UK's drug regulator completed inspection of one of its key manufacturing unit without any critical observations.
-
Wockhardt Gets Import Alert For Ankleshwar Plant, Shares Slump 14%
Wockhardt shares slumped 14 per cent on Monday, following the US Food and Drug Administration's import ban on its Ankleshwar plant for non-compliance with good manufacturing norms.
-
Wockhardt Approaches Shareholders To Raise Up To Rs 1,200 Crore
Wockhardt said it will utilise the money to re-pay or pre-pay term loan availed by it and for general corporate purposes.
-
Wockhardt Shares Rise Over 1%, Wipe Off Initial Losses
Shares in drug firm Wockhardt bounced back on Monday, wiping all its initial losses and ended the day with 1.5 per cent gains on value-buying in-line with a strong broader market sentiment.
-
Wockhardt Shares Hit Upper Limit For Second Straight Day On COVID-19 Vaccine Supply To UK
On Monday, Wockhardt entered into a fill-and-finish agreement with the UK government to supply COVID-19 vaccines
-
Wockhardt To Supply Coronavirus Vaccine To UK Government, Shares Soar 10%
Wockhardt said it will manufacture the product at its Wrexham, North Wales-based subsidiary, CP Pharmaceuticals.
-
Wockhardt To Supply COVID-19 Vaccines To UK
AstraZeneca has indicated it would need 30 million fill-and-finish doses of their vaccine candidate, which the company intends to supply in the next few months, Wockhardt's chairman said.
-
Wockhardt Rises On US FDA Nod For Cancer Drug Decitabine
Wockhardt's Decitabine Injection is a generic version of Dacogen, marketed in USA and other countries by Otsuka.
-
Wockhardt Shareholders Approve Raising Of Upto Rs 1,000 Crore
Wockhardt has three research centres and 12 manufacturing plants, with businesses ranging from the making and marketing of pharmaceuticals, active pharmaceutical ingredients (APIs) and vaccines.
-
Top 5 Pharma Companies Lose 19,000 Crore In Market Value. Here Is Why
Analysts say the fresh selloff in the pharmaceutical shares has been triggered after Sun Pharma's US-based subsidiary Taro Pharmaceuticals reported a weak set of earnings in the March quarter.
-
Wockhardt Plunges After US Drug Regulator Warns Subsidiary
After a weak opening, shares of the company further went down by 6.67 per cent to Rs 701 on BSE.
-
Wockhardt Surges 8% As German Regulator Clears Ankaleshwar Plant
Shares of pharmaceutical company Wockhardt surged as much as 8 per cent to hit intraday high of Rs 728.
-
Wockhardt Shares Jump 3% On UK Health Regulator Approval
On BSE, the scrip opened at Rs 699 and jumped 3.24 per cent to an early high of Rs 704. At 1147 hours, it was trading at Rs 689.50, up 1.11 per cent.
-
Wockhardt Tanks 5% On Weak Q2 Numbers
Shares of Drug firm Wockhardt on Friday tumbled over 5 per cent after the company reported 81.59 per cent dip in consolidated net profit to Rs 17 crore for the September quarter of the current fiscal.
-
Wockhardt Surges 5% As US Drug Regulator Excludes Drug From Import Alert
Shares of Wockhardt Ltd jumped as much as 4.75 per cent to hit intraday high of Rs 937 after the US drug regulator excluded one of its drugs from import alert it had issued to the company in August.
-
Wockhardt Rises As UK Regulator Completes Inspection Of Key Plant
Shares of drug manufacturer Wockhardt rose as much as 4.46 per cent to hit intraday high of Rs 945 after the UK's drug regulator completed inspection of one of its key manufacturing unit without any critical observations.
-
Wockhardt Gets Import Alert For Ankleshwar Plant, Shares Slump 14%
Wockhardt shares slumped 14 per cent on Monday, following the US Food and Drug Administration's import ban on its Ankleshwar plant for non-compliance with good manufacturing norms.
-
Wockhardt Approaches Shareholders To Raise Up To Rs 1,200 Crore
Wockhardt said it will utilise the money to re-pay or pre-pay term loan availed by it and for general corporate purposes.
-
Wockhardt Shares Rise Over 1%, Wipe Off Initial Losses
Shares in drug firm Wockhardt bounced back on Monday, wiping all its initial losses and ended the day with 1.5 per cent gains on value-buying in-line with a strong broader market sentiment.
